Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation
暂无分享,去创建一个
[1] M. Mostafa,et al. Low TNFAIP3 expression in psoriatic skin promotes disease susceptibility and severity , 2019, PloS one.
[2] V. Rodrigues,et al. Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients , 2019, Scientific Reports.
[3] Adriana Rendon,et al. Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.
[4] P. Vandenabeele,et al. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis. , 2019, The Journal of investigative dermatology.
[5] A. Kijlstra,et al. Decreased expression of A20 is associated with ocular Behcet’s disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease , 2018, British Journal of Ophthalmology.
[6] Raul Aguirre-Gamboa,et al. Iconography : TNF-?–induced protein 3 (TNFAIP3) /A20 acts as a master switch in TNF-? blockade–driven IL-17A expression , 2018 .
[7] Raul Aguirre-Gamboa,et al. TNF‐&agr;–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF‐&agr; blockade–driven IL‐17A expression , 2017, The Journal of allergy and clinical immunology.
[8] F. Hu,et al. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. , 2017, Journal of dermatological science.
[9] J. Li,et al. Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol , 2016, The British journal of dermatology.
[10] Jeung-Hoon Lee,et al. The inhibitory effect of A20 on the inflammatory reaction of epidermal keratinocytes. , 2016, International journal of molecular medicine.
[11] Xiaoming Liu,et al. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis. , 2015, International immunopharmacology.
[12] Yuquan Wei,et al. Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis. , 2015, International immunopharmacology.
[13] A. Menter,et al. An overview of developing TNF-α targeted therapy for the treatment of psoriasis , 2015, Expert opinion on investigational drugs.
[14] J. Koo,et al. The role of IL-17 in psoriasis , 2015, The Journal of dermatological treatment.
[15] A. Bowcock,et al. Meta-Analysis of the TNFAIP3 Region in Psoriasis Reveals a Risk Haplotype that is Distinct from Other Autoimmune Diseases , 2014, Genes and Immunity.
[16] F. Nestle,et al. TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis , 2013, European journal of immunology.
[17] S. Gaffen,et al. IL-17 signaling and A20 , 2013, Cell cycle.
[18] S. Gaffen,et al. The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling , 2013, Science Signaling.
[19] A. Ma,et al. A20: linking a complex regulator of ubiquitylation to immunity and human disease , 2012, Nature Reviews Immunology.
[20] H. Tian,et al. Expression of Tumor Necrosis Factor Alpha-Induced Protein 3 mRNA in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Psoriasis Vulgaris , 2012, Clinical and Vaccine Immunology.
[21] Jun Yan,et al. New insights of T cells in the pathogenesis of psoriasis , 2012, Cellular and Molecular Immunology.
[22] James T. Elder,et al. TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis , 2011, The Journal of investigative dermatology.
[23] C. Teuscher,et al. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. , 2011, Blood.
[24] L. Boon,et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1 , 2009, The Journal of Immunology.
[25] Rudi Beyaert,et al. A20 inhibits NF-κB activation by dual ubiquitin-editing functions , 2005 .
[26] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.